TITLE

Cost of illness of inflammatory single centre retrospective study

AUTHOR(S)
Bassi, A.; Dodd, S.; Williamson, P.; Bodger, K.
PUB. DATE
October 2004
SOURCE
Gut;Oct2004, Vol. 53 Issue 10, p1471
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: The potentially high costs of care associated with inflammatory bowel disease (IBD) are recognised but we have little knowledge of the scale, profile, or determinants of these costs in the UK. This study aimed to describe costs of illness for a group of IBD patients and determine factors associated with increased healthcare costs. Setting: A university hospital serving a target population of approximately 330 000. Patients and Methods: A six month cohort of IBD patients receiving any form of secondary care was identified, comprising 307 cases of ulcerative (or indeterminate) colitis and 172 cases of Crohn's disease. Demographic and clinical data were abstracted from clinical records and individual resource use was itemised for all attributable costs (including extraintestinal manifestations). Item costs were derived from national and local sources. Cost data were expressed as mean six month costs per patient (with 95% confidence interval (CI)) obtained using non-parametric bootstrapping. Determinants of cost were analysed using generalised linear regression modelling. A postal survey of patients was undertaken to examine indirect costs, out of pocket expenses, and primary care visits. Results:Inpatient services (medical and/or surgical) were required by 67 patients (14%) but accounted for 49% of total secondary care costs. Drug costs accounted for less than a quarter of total costs. Individual patient costs ranged from 73 to 33,254 UK £ per six months. Mean (95% CI) six month costs per patient were 1256 UK £ ( 988 £, 1721 £) for colitis and 1652 UK £ (1221 £, 2239 £) for Crohn's disease. Hospitalisation, disease severity grade, and disease extent correlated positively with cost of illness but costs were independent of age or sex. Compared with quiescent cases of IBD, disease relapse was associated with a 2-3-fold increase in costs for non-hospitalised cases and a 20-fold increase in costs for hospitalised cases. Survey data suggested average six month costs were < 30 UK £ per patient for primary care visits (both diseases) and median loss of earnings were 239 UK £ for colitis and 299 UK £ for Crohn's disease. Conclusions:This study represents the first detailed characterisation of the scale and determinants of costs of illness for IBD in a British hospital. Hospitalisation affected a minority of sufferers but accounted for half of the total direct costs falling on the healthcare system.
ACCESSION #
14674393

 

Related Articles

  • The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Kaplan, Gilaad G.; Pedersen, Bo V.; Andersson, Roland E.; Sands, Bruce E.; Korzenik, Joshua; Frisch, Morten // Gut;Oct2007, Vol. 56 Issue 10, p1387 

    Background: The relationship between appendectomy and Crohn's disease is controversial. A Swedish- Danish cohort study was conducted to assess the risk of developing Crohn's disease after an appendectomy. Methods: 709 353 appendectomy patients in Sweden (since 1964) and Denmark (since 1977) were...

  • Hydroxylases as therapeutic targets in inflammatory bowel disease. Cummins, Eoin P.; Doherty, Glen A.; Taylor, Cormac T. // Laboratory Investigation (00236837);Apr2013, Vol. 93 Issue 4, p378 

    Inflammatory bowel disease (IBD) is a common and debilitating clinical disorder comprising ulcerative colitis and Crohn disease. IBD occurs when inappropriate immunological activity in the intestinal mucosa results in epithelial barrier dysfunction leading to exposure of the mucosal immune...

  • Crohn’s disease in a Meckel’s diverticulum: report of a case. Diamond, Ivan R.; Hayes-Jordan, Andrea; Phillips, M. James; Langer, Jacob C. // Pediatric Surgery International;Mar2008, Vol. 24 Issue 3, p361 

    Meckel’s diverticulum has previously been reported to be present in patients with Crohn’s disease. However, the finding is typically an incidental one, and involvement of the diverticulum in the disease process is uncommon. We report a case of an adolescent with known...

  • Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn's disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series. Negreanu, L.; Smarandache, G.; Mateescu, R. // Techniques in Coloproctology;Mar2014, Vol. 18 Issue 3, p277 

    Background: Almost 70-80 % of patients with Crohn's disease and virtually all patients with ulcerative colitis have colorectal mucosa involvement. Colon capsule endoscopy is an interesting option for patients unable or unwilling to undergo colonoscopy. We report our experience with the...

  • Management of ulcerative colitis. Malley, John O'; Ellis, Tony // General Practice Update;Apr2009, Vol. 2 Issue 4, p29 

    Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon and rectum that is characterised by unpredictable periods of remission and relapse. Although diagnosis is not expected to occur in primary care, it can often be suspected from a physical examination and from the...

  • CITATIONS AND CLINICIANS' NOTES: CROHN'S DISEASE.  // Current Medical Literature: Gastroenterology;2005, Vol. 24 Issue 2, p40 

    Comments on previously published studies on Crohn's disease and related topics. Crohn's-like changes in the colon due to mycophenolate; Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease; Trichuris suis therapy in Crohn's disease.

  • Indications for and results of operation in inflammatory bowel disease. Schofield, P. F.; Manson, J. M. // Journal of the Royal Society of Medicine;Oct1986, Vol. 79 Issue 10, p593 

    Of 363 patients with inflammatory bowel disease presenting between 1972 and 1983, 166 required definitive operation. A classification by histological type distinguishes Crohn's disease (CD) from ulcerative colitis (UC) and indeterminate inflammatory bowel disease. CD is divided into...

  • Pouch function and quality of life after successful management of pouch-related septic complications in patients with ulcerative colitis. Mennigen, Rudolf; Senninger, Norbert; Bruewer, Matthias; Rijcken, Emile // Langenbeck's Archives of Surgery;Jan2012, Vol. 397 Issue 1, p37 

    Purpose: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis is associated with pouch-related septic complications (PRSC) in 10% of patients. This study questioned if PRSC have a negative impact on pouch function and quality of life. Patients and methods:...

  • Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn’s disease. Hatsugai, Moriaki; Kurokawa, Manae S.; Kouro, Takefumi; Nagai, Kohei; Arito, Mitsumi; Masuko, Kayo; Suematsu, Naoya; Okamoto, Kazuki; Itoh, Fumio; Kato, Tomohiro // Journal of Gastroenterology;May2010, Vol. 45 Issue 5, p488 

    Effective biomarkers for discrimination between ulcerative colitis (UC) and Crohn’s disease (CD) have not been established yet. In this study, we analyzed protein profiles of peripheral blood mononuclear cells (PBMCs) of the patients to find such a biomarker. Peripheral blood mononuclear...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics